Substance abuse and adherence to antiretroviral therapy among patients attending clinic at a specialist hospital in Jos, Nigeria by Goar, Suwa G. et al.
African Journal of Drug & Alcohol Studies, 14(1), 2015
Copyright © 2015, CRISA Publications
SuBStAnce ABuSe AnD ADherence to AntiretroVirAl therAPY AMong 
PAtientS AttenDing clinic At A SPeciAliSt hoSPitAl in JoS, nigeriA
1suwa g. goar, 1Moses D. audu, 1Michael .T. agbir, & 2Bitrus Matawal
1Department of Psychiatry, Jos University Teaching Hospital, Jos, Nigeria; 2Infectious 
Disease Unit, Plateau State Specialist Hospital, Jos, Nigeria
ABStrAct
Substance abuse does not only increase susceptibility to HIV/AIDS through high risk 
Sexual behaviors but it also hastens the progression of the disease among infected 
persons than in those who do not abuse drugs. Furthermore, drug use impairs adherence 
to antiretroviral therapy (ART) leading to reduction in ART effectiveness and ultimately 
increased HIV-related mortality. In North Central Nigeria there is a dearth of information 
concerning the influence of substance abuse on adherence to ART which has substantially 
altered the fate of HIV-infected people. The objectives of this study therefore, were 
to determine the type of substances abused by HIV-infected patients attending clinic 
at Plateau State Specialists Hospital (PSSH) and to determine the effect of substance 
abuse and sociodemographic factors on adherence to ART among these patients. 
Ethical approval was obtained before the commencement of the study which was cross-
sectional in design. The study was carried out at the infectious disease unit of the Plateau 
State Specialists Hospital, Jos among 160 consecutive patients. The Alcohol, Smoking 
and Substance Involvement Screening Test (ASSIST) was used for the assessment of the 
types of substance abused and AIDS Clinical Trials Group(ACTG) adherence instrument 
was used to assess reasons for non- adherence. The results showed that 61.9% of the 
patients did not use any substance of abuse, 38.1% either abused one substance or a 
combination of substances. Substance abuse were (p = 0.0001), alcohol abuse (p = 0.003) 
and educational status (p = 0.0001) significantly associated with non-adherence to ART 
while, age (p = 0.954), employment status (p = 0.924) and marital status (p = 0.466) were 
not. However, logistic regression revealed that only alcohol abuse (B = -1.383, df = 1, p 
= .002) predicted non adherence to ART. We recommend the screening of patients on 
ART for substance abuse and a multi-disciplinary approach to the treatment of HIV/AIDS.
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introDuction 
The impact of HIV/AIDS will continue 
to be felt for decade’s world over. Sub-
Saharan Africa remains the most affected 
region in the global HIV/AIDS epidemic. 
More than two thirds (68%) of all people 
who are HIV positive lived in Sub-Saharan 
Africa (UNAIDS/WHO/UNICEF, 2011). 
Similarly, of all AIDS deaths in 2010 more 
than three -quarters occurred in Sub-Sa-
haran Africa (UNAIDS, 2011).
In recent years efforts have been inten-
sified to increase access to effective treat-
ment and prevention. Fewer than half of 
Africans are receiving it (UNAIDS/WHO/
UNICEF, 2011). However, early confidence 
recorded with the introduction of antiret-
roviral therapy (ART) that led to significant 
reduction in HIV/AIDS associated morbid-
ity and mortality has been compromised. 
To achieve effective treatment and realize 
the benefits of treatment, strict adher-
ence to ART instructions is very critical. 
Adherence to therapy is therefore, an 
important determinant of clinical and vi-
rologic outcomes for patients who have 
been prescribed ART. Researchers have 
shown that even modest or occasional 
non-adherence can lead to emergence of 
drug resistant viral strains and the trans-
mission of these viral strains in the popu-
lation (Gifford, 2000; Liu, et al., 2001).
Unfortunately, poor adherence to ART 
is a common problem with more than half 
of individuals on combination therapies 
failing to take their medication with re-
spect to dosage, time and dietary instruc-
tion (Murphy et al., 2001; Nieuwker et al., 
2001). Although there are several reasons 
for treatment failure among HIV infected 
patients, co morbid substance abuse con-
tributes significantly to non-adherence. 
HIV infected drug abusers may among 
other factors have mental health prob-
lems, medical conditions and sub-optimal 
support. These have been shown to tam-
per with adherence to medication (Komiti 
et al., 2003, Murphy et al., 2004).
The effect of alcohol use on adherence 
to antiretroviral therapy has also been re-
ported in a meta-analysis by Henderhot 
et al (2009). In this study, approximately 
50-60% of alcohol drinkers were found to 
be less likely adherent to ART compared to 
abstainers or those who drank relatively 
less and several variables were found to 
moderate the alcohol-adherence associa-
tion. In a related study by Braithwaite et al 
(2005b) of a temporal and dose response 
association between alcohol consumption 
and ART adherence revealed the relative 
risk of non-adherence associated with al-
cohol consumption to be 1.5 on non-binge 
drinking days but 2.7 on binge drinking 
days. Daily binge alcohol consumption 
was therefore, found to decrease survival 
from 28.1 years to 21.4 years which corre-
sponded to a 24 percent decrease.
There is increasing evidence showing 
that alcohol impacts negatively on HIV 
disease through various mechanisms 
namely: HIV transmission, hasten pro-
gression and non adherence to ART. Al-
cohol has been associated with the likeli-
hood of HIV-infected individuals engaging 
in sexual risk behavior, thereby re-infect-
ing themselves with a different strain 
and or infecting others (Kalichman et al., 
2007). The same holds true for the use of 
other psychoactive substances. Alcohol 
hastens HIV disease progression through 
its action on proteasomes and immune-
proteasomes which impede critical im-
mune processes during progressive HIV-1 
infection (Haorah et al., 2004). It has also 
been found that alcohol-exacerbated 
hepatoxicity could reduce the efficiency 
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of the liver. Consequently, it leads to re-
duction in bioavailability of ART needed 
to suppress the replication of HIV (Coni-
gliaro et al., 2003). Furthermore, the as-
sociation between alcohol abuse and HIV 
disease progression is also caused by non 
adherence to ART (Samet et al., 2003). 
For instance, HIV-infected individuals who 
use alcohol may less likely take their pre-
scribed medication appropriately. 
Some studies in Africa have shown 
high levels of adherence to ART amongst 
HIV-infected patients. However, recent 
reviews have shown the need for an in-
creased focus on ART adherence. Hence, 
it is necessarily important to pay atten-
tion to screening of substance use among 
HIV-infected persons in order to reduce 
individual’s chances of engaging in sexual 
risk behaviors; reduce the rates of non ad-
herence to ART and slow down the rate 
of disease progression especially among 
those who are receiving ART. Therefore, 
this study was undertaken to assess the 
types of substances abused and second-
ly, to determine the effect of substance 
abuse and sociodemographic factors on 
adherence to ART among people living 
with HIV/AIDS receiving treatment at Pla-
teau State Specialist Hospital Jos, Nigeria.
MethoD
The study was carried out at the infec-
tious diseases unit of the Plateau State 
Specialist Hospital, Jos. Jos is the capital 
city of Plateau state. It is located in North 
central Nigeria and has an estimated 
population of 822,837 as at 2006 (Plateau 
State Ministry of Information). It offers 
both specialist and primary care services 
to in and out patients. This hospital serves 
as a reference centre for the seventeen 
government owned general hospitals 
spread across the state.
Ethical approval was obtained before 
the commencement of the study which 
was cross-sectional in design. A total of 
160 patients were recruited for this study. 
Every consecutive consented patient aged 
18 years and above that attended the in-
fectious diseases unit with a diagnosis of 
HIV-infection was recruited for the study. 
This was done until the desired sample 
size of 160 was obtained. A participant 
must also have been on antiretroviral 
drugs for at least one month to be quali-
fied for inclusion. Excluded were patients 
with chronic medical conditions, patients 
with other psychiatric conditions beside 
substance abuse, patients with altered 
sensorium and those who did not con-
sent. Non adherence was assessed using 
self reported questionnaire. Self reported 
questionnaire has been used for evaluat-
ing adherence to ART in different parts 
of sub-Saharan Africa (Nwauche et al., 
2006). Although self reported outcomes 
of adherence may have a weakness of 
reliability, a study by Oyugi et al (2004) 
found no significant difference between 
patient-reported and objective measures 
of adherence. In this study patients were 
asked if they had missed dosage or timing 
of ART in the past seven days. They were 
asked to recall starting from the day of in-
terview if they have taken medication late 
with 2 hours or missed in the last seven 
days. Adherence to ART was considered 
optimal if patients reported no to both 
questions. Focus was on recent adher-
ence in order to maximize recall and mini-
mize bias. 
AIDS Clinical Trials Group (ACTG) ques-
tionnaire was used to assess reasons for 
non-adherence. The Alcohol, Smoking 
and Substance Involvement Screening 
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Test (ASSIST) developed by WHO was used 
for assessing substance abuse in the last 
one month. ASSIST has been shown to be 
cross culturally valid and reliable screen-
ing test (New come 2005). A score of 11 
points and above for alcohol and 4 points 
and above for all other substances was re-
garded as harmful use (abuse). Substanc-
es in this study are defined broadly to in-
clude alcohol, tobacco, illicit drugs and le-
gal pharmaceutical agents that have high 
dependent potential. A semi-structured 
questionnaire was used to collect socio-
demographic data.
Data was coded and analyzed using sta-
tistical package for social sciences SPSS 
15. Frequency, cross tabulations and chi 
square were used to compare variables. 
The level of significance was set at p < 
0.05. 
reSultS
The study showed that 55(34.4%) of the 
respondents were non-adherents. Table 1 
shows that 99(61.9%) of the study sample 
did not use any substance of abuse while 
66(38.1%) either abused one substance 
or combination of substances. The most 
abused of all the substances was alcohol 
27(16.9%), followed by 11(6.9%) coffee. 
Others were 7(4.4%) analgesics, 5(3.1 %) 
antihistamines, 3(1.9%) cigarettes and 
8(5.0%) others.
Table 2 shows that slightly great-
er than half 32(58.2%) of those who 
abused substances were non-adherents 
compared to 23(41.8%) who did not 
abuse substances. Higher proportion, 
76(72.4%) of those who did not abuse 
substances were adherent to medica-
tion compared to only 29(27.6%) who 
abused substances. Those who did not 
abuse substances were significantly bet-
ter adherents than those who abused 
substances (x2 = 14.292, df = 1, p = 0.000). 
The abuse of alcohol was associated 
with non adherence to ART (x2 = 8.916, 
df = 1, p = 0.003). The respondents’ age 
ranged from 18 to 68 years old with a 
mean of 35.6 ± 8.67. The peak age group 
was 25-34 years representing 45% of the 
study sample. This group had the high-
est percentage 24(43.6%) of non-adher-
ents. However, there was no significant 
relationship between age and adher-
ence to medication (x2 = 0.333, df = 3, p 
= 0.954). There was a preponderance of 
females 103(64.4%) and only 57(35.6%) 
were males. Females had higher per-
centage of both adherents 70(66.7%) 
and non-adherents 33(60.0%). There 
was no statistical significance between 
sex and adherence to medication (x2= 
0.699, df = 1, p = 0.403). The married 
respondents 56(53.3%) had higher per-
centage of adherents compared to the 
singles 49(46.7%) (x2 = 0.531, df = 1, p = 
0.466). More 22(40.0%) of the respon-
dents who had no formal education 
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Table 1. Frequency and types of 
substances abused
variables Frequency(n) %
No substance abuse 99 61.9
Substance abuse 66 38.1
Total 165 100









were non adherents compared to only 
10(18.2%) who had post secondary edu-
cation. Those who had post secondary 
education 47(44.8%) were better adher-
ents compared to those with no formal 
education 10(9.5%). There was a signifi-
cant relationship between educational 
level and adherence to medication (x2 = 
25.490, df = 3, p = 0.001)
Reasons given for non-adherence to aRT
As shown in Table 3, the most prominent 
reasons for non-adherence were: simply 
forgot (13.8%), avoid side effects (12.5%), 
away from home (10.0%) and being busy 
(7.5%). The results of logistic regression 
analysis reported in Table 4 show that only 
alcohol abuse predicted non-adherence to 
ART (B = -1.383, df = 1, P = 0.002)
Table 2. Relationship between substance abuse, alcohol abuse, socio-demographic 
factors and adherence to ART 
variables Non adherents adherents statistic
No substance abuse 23(41.8%) 76(72.4%) x2 = 14.292
Substance abuse 32(58.2%) 29(27.6%) df = 1
Total 55(100) 105(100) p = 0.001
No alcohol use 39(70.9%) 94(89.5%) x2 = 8.916
Alcohol use 16(29.1%) 11(10.5%) df =1
Total 55(100) 105(100) p = 0.003
age groups
15 – 24 5(9.1%) 7(67%) x2 = 0.333
25 – 34 24(43.0%) 48(45.7%) df  = 3
35 – 44 17(30.9%) 32(30.5) p = 0.954
45 and above 9(16.4%) 18(17.1%)
Total 55(100) 105(100)
Sex
Male 22(40.0%) 35(33.3%) x2  = 0.699
Female 33(60.0%) 70(66.7%) df = 1
Total 55(100) 105(100) p = 0.403
Marital status
Single 29(52.7%) 49(46.7%) x2  = 0.531
Married 26(47.3%) 56(53.3%) df = 1
Total 55(100) 105(100) p = 0.466 
Employment status 
Unemployed 23(41.8%) 42(33.3%)  x2 = 0.049
Employed 32(58.2%) 70(66.7%) df = 1
Total 55(100) 105(100) p = 0.924
Educational status 
No formal education 22(40.0%) 10(9.5%) x2 = 25.490
Primary 9(16.4%) 12(11.4%) df = 3
Secondary 14(25.5%) 36(34.3%) p = 0.001
Post secondary 10(18.2%) 47(44.8%)
Total 55(100) 105(100)
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DiScuSSion
The prevalence rate of non-adherence 
in this study was 34.6%. This is in agree-
ment with earlier studies done in this 
country (Erah and Arute., 2008), other 
parts of Africa (Kalichman et al., 2007) 
and in the Western countries (Mills et al., 
2006). 
High prevalence of substance abuse 
(39.1%) with alcohol being the most 
abused was found in this study. This con-
curs with several other studies that have 
demonstrated high prevalence of alcohol 
abuse among individuals with HIV/AIDS 
(Chander et al., 2008, Galvan et al., 2002). 
People with substance related problems 
are more likely to contract HIV because 
they tend to engage in behavior that plac-
es them at risk (Malow et al., 2001; Audu 
et al., 2010). They are also more likely to 
abuse substances either as an expression 
of maladaptive coping strategy or due to 
the presence of other co-morbid psychi-
atric conditions which are prevalent in 
patients with HIV/AIDS (Olley et al., 2003; 
Pence et al., 2008).
A significant relationship between alco-
hol abuse and non-adherence to ART was 
found. This is in agreement with a study 
done by (Hendershot et al., 2009) that 
showed that HIV infected patients with 
co-morbid alcohol abuse contribute sig-
nificantly to non-adherence. There are va-
riety of ways by which drinking can com-
promise ART adherence. For instance, 
intoxication impairs memory, planning, 
organizational skills and other cognitive 
abilities that can result in missed dos-
es or timing of medication (Aloisi et al, 
2002; Braithwaite et al, 2007). Recently, 
a study revealed that patients who take 
ART and abuse alcohol had intentionally 
stopped taking their medication based 
on the belief that mixing alcohol and ART 
Table 4. Logistic regression analysis showing association between non-adherence to 
ART and predictors
variables B s.E wald df sig Exp(B)
Alcohol use -1.383 .454 9.270 1 .002 .251
Agegrp .081 .229 .124 1 .725 1.084
Marital status .283 .407 .485 1 .486 1.328
Employstatus .043 .380 .013 1 .911 1.044
Edustatus -.557 .402 1.923 1 .166  .573
Sex .114 .388  .086 1  .770 1.120 
Constant  .871 .887  .964 1  .326 2.390
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Table 3. Reasons for non-adherence to 
antiretroviral drugs 
variables Frequency (n) %
Avoid side effects 20 12.5
Overwhelmed 6 3.8
Many pills 3 1.9
Not want others to know 3 1.9
Drug toxic 6 3.8
Simply forget 22 13.8
Away from home 16 10.0
Being busy 12 7.5
Change in routine 6 3.8
Slept off 6 3.8
Specific time 2 1.3
Felt sick 5 3.1
Total 107 100
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is very toxic to the liver (Kalichman et 
al., 2012). It has also been shown to ex-
acerbate emotional distress in HIV posi-
tive individuals which has the capacity to 
tamper with adherence to ART (Komiti et 
al., 2003). Additionally, HIV infected drug 
abusers may among other factors have 
mental health problems, medical condi-
tions and sub-optimal social support that 
have been found to interfere with adher-
ence to medication (Chesney et al., 2000). 
However, aside alcohol abuse there are 
other several factors that have been asso-
ciated with non-adherence to active anti-
retroviral treatment among HIV patients. 
These include individual characteristics 
such as gastro-intestinal conditions that 
interfere with response to medication, 
existing resistance to medication and to 
inability to adhere to treatment. Optimal 
adherence (≥85%) to antiretroviral regi-
men is required to achieve viral suppres-
sion in people living with HIV. In spite of 
this, there are often approximately 80% 
of patients with undetectable viral loads 
(Peterson et al., 2000). This is even more 
critical in Nigeria where majority of the 
people live below the poverty line and 
have to travel long distances to treatment 
centers that have poor facilities.
Studies on the relationship between 
medication adherence and socio-demo-
graphic factors have not been consistent. 
Some researchers have demonstrated 
that male sex, older age, higher income 
and higher education correlate with 
better adherence (Ickovics et al., 2002; 
Nwauche et al., 2006). It has also been 
found that adherence increases with age 
(Ghidei et al., 2013) except in the most el-
derly (those aged over 75 years). This may 
be because the elderly usually have more 
complex medical regimens and more 
co-morbidity, such as visual, hearing or 
memory impairment. On the contrary, 
Barclay et al, (2007) found that the rate of 
poor adherence was twice as high among 
younger patients (68%) than with older 
individuals (33%).
Although in our study there was a 
higher percentage of non-adherence in 
the younger age groups 25-34 and 35-44 
years, it was not statistically significant. 
The non-adherence may have been in-
fluenced by the higher rate of substance 
abuse in the younger age groups which 
have been shown to compromise adher-
ence to ART.
There was a preponderance of female 
participants in this study which reflects 
the fact that the rate of HIV infection is 
higher in women than men. However, 
there was no significant association be-
tween gender and medication adherence. 
This finding is in contrast to the study that 
was carried out in Port Harcourt, Nigeria 
by Nwauche, (2006) and in United States 
by Berg et al, (2004) who found that gen-
der has influence on adherence to anti-
retroviral therapy.
In this study the percentage of the non 
adherents in the unemployed was more 
than the employed. There was no signifi-
cant relationship between employment 
status and adherence to medication. This 
finding is in agreement with study done 
by Erah and Arute (2008). This may be 
explainable by the fact that antiretroviral 
drugs are free. Furthermore, it has also 
been shown that the positive effect of 
free treatment is often offset by indirect 
transportation costs in areas where pa-
tients live far away from health facilities 
(Mills et al., 2006). In addition, research-
ers had found that health services fees 
and cost of transportation are associated 
with lower adherence to ART (Mills et al., 
2006). 
SUBSTANCE ABUSE AND ADHERENCE TO ART
44
High levels of education have been 
associated with increased adherence to 
ART (Peltzer and Pengpid, 2013; Stone., 
2004) This was replicated in this study, 
people with higher level of education 
generally have greater access to infor-
mation and are more likely to stick to in-
formed decisions.
Some common reasons for missing 
medications have been simply forgot 
66%, being busy 53%, away from home 
57% and change in routine (Chesney et 
al., 2000, Talam et al., 2008). In this study 
we found simply forgot (13.8%) avoid-
ing side effects 12.5%, away from home 
10% and being busy 7.5%, were the com-
mon reasons. These reasons may have 
been associated with improved in health 
and patients may likely be working away 
from home and or lack of social support 
and cognitive impairment from substance 
abuse (Gonzalez et al, 2004).
In conclusion, this study underscores 
the critical importance of establishing a 
comprehensive therapeutic alliance be-
tween clinicians and patients to assess 
and address factors that tamper with 
treatment adherence. Most especially, in 
scarce resource countries where the sec-
ond line treatment regimen is not read-
ily available if resistance is developed to 
the first line regimen. Fortunately, most 
of these factors are amenable to medical 
and behavioral intervention once they are 
identified. Therefore, it is necessarily im-
portant to screen all patients on ART for 
substance abuse and to give clear instruc-
tions about regimen and it should be tai-
lored to fit the individual lifestyle in other 
to achieve optimum benefits.
The study has several limitations most 
especially the sample size which was 
small and may not be a true reflection of 
what is happening and in other centers 
across the state. A diagnostic rather than 
screening instrument would have given 
clearer clinical picture of the magnitude 
of the problem. Furthermore, confound-
ing variables such as psychosocial factors 
were not controlled which may have influ-
enced the association between substance 
use and adherence to ART.
We suggest that further study in this 
area should look at psychosocial factors 
and the temporal relationship between 
substance misuse and adherence to ART 
in our environment.
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